Loading...
•
Mar 31, 2021
Amedisys Q1 2021 Earnings Report
Amedisys reported strong first-quarter results, driven by home health performance and hospice progress despite COVID-19 impacts.
Key Takeaways
Amedisys reported a revenue increase of $45.4 million, reaching $537.1 million, and net income attributable to Amedisys, Inc. of $49.9 million. The company's Home Health segment showed strong momentum, while the Hospice segment continued to navigate COVID-19 challenges. Amedisys is focused on innovation, inorganic growth, and cash flow generation, positioning itself as a leader in industry consolidation.
Net service revenue increased to $537.1 million compared to $491.7 million in 2020.
Net income attributable to Amedisys, Inc. reached $49.9 million, up from $31.8 million in 2020.
Adjusted net income attributable to Amedisys, Inc. per diluted share was $1.54, compared to $1.05 in 2020.
The company updated its 2021 guidance to reflect the extension of the suspension of sequestration through December 31, 2021.
Amedisys
Amedisys
Forward Guidance
Amedisys updated its 2021 revenue guidance to $2.302 billion - $2.342 billion, adjusted EBITDA to $342 million - $352 million, and adjusted diluted EPS to $6.85 - $7.07, reflecting the extension of the suspension of sequestration through December 31, 2021. This excludes any impacts from future acquisitions.
Positive Outlook
- Net service revenue is anticipated to be in the range of $2.302 billion to $2.342 billion.
- Adjusted EBITDA is anticipated to be in the range of $342 million to $352 million.
- Adjusted diluted earnings per share is anticipated to be in the range of $6.85 to $7.07.
- Guidance reflects the extension of the suspension of sequestration through December 31, 2021.
- The company expects to be at the forefront of industry consolidation.
Challenges Ahead
- Guidance excludes the effects of any future acquisitions.
- The home health, hospice and personal care industries are highly competitive.
- The industries are subject to intensive regulations.
- Trends are subject to numerous factors, risks, and uncertainties.
- The COVID-19 pandemic continues to impact business, financial condition and results of operations.